Abstract

O-linked β-N-acetylglucosamine (O-GlcNAc) is an abundant and essential intracellular form of protein glycosylation in animals and plants. In humans, dysregulation of O-GlcNAcylation occurs in a wide range of diseases, including cancer, diabetes, and neurodegeneration. Since its discovery more than 30 years ago, great strides have been made in understanding central aspects of O-GlcNAc signaling, including identifying thousands of its substrates and characterizing the enzymes that govern it. However, while many O-GlcNAcylated proteins have been reported, only a small subset of these change their glycosylation status in response to a typical stimulus or stress. Identifying the functionally important O-GlcNAcylation changes in any given signaling context remains a significant challenge in the field. To address this need, we leveraged chemical biology and quantitative mass spectrometry methods to create a new glycoproteomics workflow for profiling stimulus-dependent changes in O-GlcNAcylated proteins. In proof-of-principle experiments, we used this new workflow to interrogate changes in O-GlcNAc substrates in mammalian protein trafficking pathways. Interestingly, our results revealed dynamic O-GlcNAcylation of COPγ1, an essential component of the coat protein I (COPI) complex that mediates Golgi protein trafficking. Moreover, we detected 11 O-GlcNAc moieties on COPγ1 and found that this modification is reduced by a model secretory stress that halts COPI trafficking. Our results suggest that O-GlcNAcylation may regulate the mammalian COPI system, analogous to its previously reported roles in other protein trafficking pathways. More broadly, our glycoproteomics workflow is applicable to myriad systems and stimuli, empowering future studies of O-GlcNAc in a host of biological contexts.

Highlights

  • O-linked β-N-acetylglucosamine (O-GlcNAc) is a major, dynamic post-translational modification (PTM), added by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA) from serine and threonine residues of intracellular proteins [1,2,3,4,5,6,7]

  • All cells are mixed, nuclear and cytoplasmic extracts are prepared by standard biochemical fractionation and labeled O-GlcNAc substrates are covalently ligated to alkyne-functionalized agarose beads via a click reaction, permitting extremely stringent washing

  • The captured and washed glycoproteins are trypsinized on-bead, and the resulting peptides are analyzed by SILAC mass spectrometry (MS) proteomics, providing an unbiased quantitation of stimulusdependent changes in O-GlcNAcylated proteins

Read more

Summary

Introduction

O-linked β-N-acetylglucosamine (O-GlcNAc) is a major, dynamic post-translational modification (PTM), added by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA) from serine and threonine residues of intracellular proteins [1,2,3,4,5,6,7]. Aberrant O-GlcNAc cycling is implicated in numerous human diseases, including cancer [2, 9,10,11,12], diabetes [13,14,15,16], cardiac dysfunction [17,18,19,20], and neurodegeneration [21,22,23,24]. Despite this broad pathophysiological significance, major questions about O-GlcNAc signaling remain. Because O-GlcNAc is a transient and sub-stoichiometric PTM, it can be difficult to study with traditional molecular biology or genetics alone

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call